Dorflex
Not available in the USCommon in Brazil
Active ingredient: dipyrone (metamizole sodium) + orphenadrine citrate + caffeine
Dorflex is not available in the US
Why it isn't sold here
Contains dipyrone (metamizole), removed from the US market in 1977 and never FDA-approved (agranulocytosis risk); this fixed combination has no US counterpart. Orphenadrine alone is available in the US (Norflex, Rx) but not in this product.
What's in it
- dipyronewithdrawn from the US market in 1977 over agranulocytosis riskBanned in the US
- orphenadrineavailable in the US by prescription as a muscle relaxantSold in the US (Rx)
- caffeinesold over the counter in the USSold in the US (OTC)
Ingredient statuses are shown for information only. This is not a substitute for the product and not medical advice.
Bringing it into the US
The FDA generally does not allow importing unapproved medicines. Personal importation is only a limited enforcement discretion — typically up to a 90-day supply for a serious condition with no US treatment, and controlled substances are effectively barred. Do not buy from gray-market pharmacies.
FDA personal importation policy →This is general information, not medical advice. Talk to your doctor or pharmacist before starting, stopping, or substituting any medicine.
Prices shown by FineRx are estimates based on recently observed pricing data and may change at any time. Final price is determined by the pharmacy or applicable savings provider.
FineRx does not provide medical advice, diagnosis, or treatment recommendations. Medication and prescription questions should be discussed with a qualified healthcare professional or pharmacist.
FineRx is an independent price comparison service. Pharmacy and third-party names may be shown for identification and comparison purposes.